carbidopa and kynurenine

carbidopa has been researched along with kynurenine in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (33.33)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Hall-Tipping, DL; Joseph, MH	1
Fine, RM	1
Baker, H; Gauthier, S; Magnussen, I; Osterland, CK; Sternberg, EM; Van Woert, MH; Young, SN	1
Bhutia, YD; Ganapathy, V; Gonchigar, S; Miyauchi, S; Ogura, J; Shimono, K; Yang, S	1
Agudelo, LZ; Brazaitis, M; Cervenka, I; Dadvar, S; Ferreira, DMS; Furrer, R; Handschin, C; Izadi, M; Kamandulis, S; Ketscher, L; Lanner, JT; Ruas, JL; Venckunas, T; Zhengye, L	1
Bhutia, YD; Ibrahim, AF; Korac, K; Rajasekaran, D; Schniers, BK; Sniegowski, T	1

Trials

1 trial(s) available for carbidopa and kynurenine

Article	Year
Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa. The New England journal of medicine, 1980, Oct-02, Volume: 303, Issue:14 Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Carbidopa; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Kynurenine; Levodopa; Male; Middle Aged; Myoclonus; Parkinson Disease; Scleroderma, Systemic; Serotonin	1980

Article

Year

Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.

The New England journal of medicine, 1980, Oct-02, Volume: 303, Issue:14

Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Carbidopa; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Kynurenine; Levodopa; Male; Middle Aged; Myoclonus; Parkinson Disease; Scleroderma, Systemic; Serotonin

1980

Other Studies

5 other study(ies) available for carbidopa and kynurenine

Article	Year
The metabolism of a tryptophan load in rat brain and liver: the influence of L-alpha-methyldopa hydrazine (MK-486, Carbidopa). Biochemical Society transactions, 1978, Volume: 6, Issue:5 Topics: Animals; Brain; Carbidopa; Hydrazines; Kynurenine; Liver; Male; Metabolic Clearance Rate; Rats; Tryptophan; Tryptophan Oxygenase	1978
Drug-related scleroderma-like illness. The Fine page. International journal of dermatology, 1981, Volume: 20, Issue:5 Topics: 5-Hydroxytryptophan; Carbidopa; Drug Combinations; Humans; Kynurenine; Scleroderma, Systemic	1981
Carbidopa is an activator of aryl hydrocarbon receptor with potential for cancer therapy. The Biochemical journal, 2017, 09-28, Volume: 474, Issue:20 Topics: Active Transport, Cell Nucleus; Aryl Hydrocarbon Hydroxylases; Carbidopa; Cell Nucleus; Hep G2 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Liver Neoplasms; Neoplasm Proteins; Pancreatic Neoplasms; Receptors, Aryl Hydrocarbon; Signal Transduction	2017
Skeletal muscle PGC-1α1 reroutes kynurenine metabolism to increase energy efficiency and fatigue-resistance. Nature communications, 2019, 06-24, Volume: 10, Issue:1 Topics: Adaptation, Physiological; Animals; Aspartate Aminotransferases; Aspartic Acid; Carbidopa; Cell Respiration; Energy Metabolism; Fatigue; Glycolysis; Kynurenine; Malates; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Models, Animal; Muscle, Skeletal; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Physical Conditioning, Animal; Protein Isoforms; Transaminases	2019
Carbidopa, an activator of aryl hydrocarbon receptor, suppresses IDO1 expression in pancreatic cancer and decreases tumor growth. The Biochemical journal, 2022, 09-16, Volume: 479, Issue:17 Topics: Animals; Carbidopa; Indoleamine-Pyrrole 2,3,-Dioxygenase; Janus Kinases; Kynurenine; Mice; Mice, Nude; Pancreatic Neoplasms; Receptors, Aryl Hydrocarbon; Signal Transduction; STAT Transcription Factors; Tryptophan	2022